Agricultural Bank of China Limited (601288.SS) vs Merck & Co., Inc. (MRK)

Agricultural Bank of China Limited is a major state-controlled Chinese commercial bank with roots in rural finance and a broad national banking network. It provides deposits, loans, payments, cards, wealth management, and corporate banking services to individuals, small businesses, large enterprises, and public-sector clients. The bank is important to China’s agricultural, county-level, and inclusive-finance systems. Its results are affected by loan growth, interest margins, asset quality, rural development policy, and the wider Chinese economy.

Merck & Co., Inc. develops pharmaceutical products across multiple therapeutic areas, including cardiometabolic disorders, oncology, and infectious diseases. In cancer treatment, its immuno-oncology portfolio, led by Keytruda, represents a significant driver of total revenue. The company also maintains a strong vaccines business focused on preventing pediatric illnesses, alongside Gardasil for human papillomavirus. In addition, Merck markets animal health products. Geographically, 47% of the company’s sales come from its U.S. human health segment, which includes pharmaceuticals and vaccines.